Retmarker now available in Europe
Critical Health has announced that Retmarker, its software solution for decision support in the ophthalmology domain, attained the right to hold the CE 0197 branding, that classifies it as a Class IIa Medical Device at a European level.
Critical Health has announced that Retmarker, its software solution for decision support in the ophthalmology domain, attained the right to hold the CE 0197 branding, that classifies it as a Class IIa Medical Device at a European level. This certification enables the company to start commercializing this software tool, which allows for a detailed analysis, using non-invasive imaging methods, of several retinal pathologies.
Available in several versions, RetmarkerDR monitors the progression of diabetic retinopathy using advanced proprietary algorithms that help ophthalmologists detect and calculate the formation and disappearance rates of microaneurysms in the retina. This allows them to infer, with the help of this information, the evolution of a disease that is one of the fastest growing causes of preventable blindness in developed countries. RetmarkerC enables the detection of changes in the retina due to several pathologies. Finally RetmarkerAMD is a new solution in development that enables the computer-assisted marking of digital images of patients with AMD, the main cause of blindness in persons over 50, in developed countries.
